{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:25:42Z","timestamp":1787729142679,"version":"build-2784847793"},"reference-count":63,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Womens Health (Lond Engl)"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:p> 'Bioidentical hormones' is a term created by the lay media to refer to chemicals derived from plants that are modified to be structurally identical to endogenous human hormones. These compounds include estradiol, estrone, estriol, progesterone, testosterone and dehydroepiandrosterone when prescribed for menopausal women. Patients assume bioidentical hormones are natural and safer than synthetic hormones with regard to the risk of developing breast cancer and other diseases, but there is little evidence to support this belief. Proponents of this therapy also support the use of salivary hormone measurements to adjust doses of these hormones instead of adjustment based on improvement or lack of improvement in menopausal symptoms. In this review, the rationale behind the use of bioidentical hormones is discussed, along with the evidence supporting the use of compounded and FDA-approved bioidentical products. <\/jats:p>","DOI":"10.2217\/17455057.4.2.163","type":"journal-article","created":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T16:22:31Z","timestamp":1235751751000},"page":"163-171","source":"Crossref","is-referenced-by-count":20,"title":["Bioidentical Hormones for Menopausal Therapy"],"prefix":"10.1177","volume":"4","author":[{"given":"Cynthia K","family":"Sites","sequence":"first","affiliation":[{"name":"The University of Alabama at Birmingham, Department of Obstetrics & Gynecology, Division of Reproductive Endocrinology & Infertility, 340 OHB, 619 19th Street South, Birmingham, AL 35249, USA, Tel.: +1 205 934 1030; Fax: +1 205 975 5732;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2008,3,1]]},"reference":[{"key":"bibr01-17455057.4.2.163","unstructured":"Papers of special note have been highlighted as either of interest (\u2022) or of considerable interest (\u2022\u2022) to readers."},{"issue":"3","key":"bibr1-17455057.4.2.163","first-page":"351","volume":"96","author":"Dennerstein L","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"bibr2-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2005.066936"},{"key":"bibr3-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"key":"bibr05-17455057.4.2.163","unstructured":"Very important large, randomized, controlled trial of the effect of nonbioidentical hormones on various clinical disease end points."},{"key":"bibr4-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.7.605"},{"key":"bibr5-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2006.0311"},{"key":"bibr08-17455057.4.2.163","unstructured":"Important review."},{"key":"bibr6-17455057.4.2.163","unstructured":"Understanding the controversy: hormone testing and bioidentical hormones. Proceedings of the Postgraduate Course; 17th Annual Meeting of the North American Menopause Society, Nashville, TN, USA, 11 October 2006."},{"key":"bibr7-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1086\/507341"},{"key":"bibr8-17455057.4.2.163","volume-title":"The Sexy Years: Discover the Hormone Connection \u2013 the Secret to Fabulous Sex, Great Health, and Vitality for Women and Men.","author":"Somers S","year":"2004"},{"key":"bibr9-17455057.4.2.163","volume-title":"The Miracle of Bio-Identical Hormones: A Revolutionary Approach to Wellness for Men, Women, and Children.","author":"Platt ME","year":"2006"},{"key":"bibr10-17455057.4.2.163","volume-title":"Clinical Gynecologic Endocrinology and Infertility.","author":"Speroff L","year":"1995"},{"key":"bibr11-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(73)90353-X"},{"key":"bibr12-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1159\/000401992"},{"key":"bibr13-17455057.4.2.163","first-page":"1341","volume":"35","author":"Lemon HM","year":"1975","journal-title":"Cancer Res."},{"key":"bibr14-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871215)60:12<2873::AID-CNCR2820601204>3.0.CO;2-B"},{"key":"bibr15-17455057.4.2.163","first-page":"17","volume":"233","author":"Lemon HM","year":"1980","journal-title":"Acta Endocrinol. Suppl. (Copenh.)"},{"key":"bibr16-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-200112000-00024"},{"key":"bibr17-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1097\/01.GME.0000094356.92081.EF"},{"key":"bibr021-17455057.4.2.163","unstructured":"Excellent review focusing on pharmacology."},{"key":"bibr18-17455057.4.2.163","volume-title":"Drug Facts and Comparisons","year":"2001","edition":"5"},{"key":"bibr19-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1097\/01.GME.0000077620.13164.62"},{"key":"bibr024-17455057.4.2.163","unstructured":"Important trial of vaginal estriol for urogenital outcomes."},{"key":"bibr20-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.3.4979"},{"key":"bibr21-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1124\/mi.5.6.7"},{"key":"bibr22-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e31803167ab"},{"key":"bibr23-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1586\/17474108.2.4.423"},{"key":"bibr24-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1097\/01.gme.0000191881.52175.8c"},{"key":"bibr25-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000284450.51264.31"},{"key":"bibr26-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000254160.62588.41"},{"key":"bibr032-17455057.4.2.163","unstructured":"Excellent paper that provided support for the introduction of Elestrin\u2122."},{"key":"bibr27-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000157116.23249.52"},{"key":"bibr28-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530290040035"},{"key":"bibr035-17455057.4.2.163","unstructured":"Classic paper that considered various progestin or progesterone regimens with conjugated estrogens on endometrial histology."},{"key":"bibr29-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1097\/00042192-200101000-00004"},{"key":"bibr30-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1080\/cmt.6.2.104.111"},{"key":"bibr31-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1080\/09513590500128583"},{"key":"bibr32-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)03430-3"},{"key":"bibr33-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2007.tb01210.x"},{"key":"bibr34-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60044-X"},{"key":"bibr35-17455057.4.2.163","volume-title":"The Multiple Roles of a Remarkable Hormone.","author":"Lee J","year":"1993"},{"key":"bibr36-17455057.4.2.163","volume-title":"What Your Doctor May Not Tell You About Breast Cancer! How Hormone Balance Can Help Save Your Life.","author":"Lee JR","year":"2002"},{"key":"bibr37-17455057.4.2.163","doi-asserted-by":"crossref","unstructured":"Bachmann G, Bancroft J, Braunstein G, Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. BLL Publishing, CA, USA 77(4), 660\u2013665 (2002).","DOI":"10.1016\/S0015-0282(02)02969-2"},{"issue":"6","key":"bibr38-17455057.4.2.163","first-page":"919","volume":"82","author":"Hickock LR","year":"1993","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"bibr39-17455057.4.2.163","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1210\/jc.2003-031564","volume":"89","author":"Chiuve SE","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"bibr40-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02065"},{"key":"bibr41-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1747"},{"key":"bibr049-17455057.4.2.163","unstructured":"Important paper regarding the transdermal testosterone patch for postmenopausal women."},{"key":"bibr42-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dml055"},{"key":"bibr43-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1258\/175404507780796370"},{"issue":"5","key":"bibr44-17455057.4.2.163","first-page":"39","volume":"9","author":"Walker CR","year":"2001","journal-title":"Adv. Nurse Pract."},{"key":"bibr45-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1177\/00220345790580120701"},{"key":"bibr46-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(01)00250-X"},{"key":"bibr47-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06025"},{"key":"bibr48-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200511000-00059"},{"key":"bibr49-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1007\/BF03192300"},{"key":"bibr50-17455057.4.2.163","doi-asserted-by":"publisher","DOI":"10.1007\/BF03192299"},{"key":"bibr101-17455057.4.2.163","unstructured":"Federal and state role in pharmacy compounding and reconstitution: exploring the right to mix to protect patients. US FDA, October 23, 2003. www.fda.gov\/o\/2\/2002\/pharmacycompound1023.html"},{"key":"bibr102-17455057.4.2.163","unstructured":"The Endocrine Society. Bioidentical Hormones. Position Statement. www.endo-society.org\/publicpolicy\/policy\/upload\/BH_Position_Statement_final_10_25_06_w_Header.pdf Accessed September 19, 2006."},{"key":"bibr103-17455057.4.2.163","unstructured":"Divigel Official FDA information: side effects and uses. www.drugs.com\/pro\/divigel.html"},{"key":"bibr104-17455057.4.2.163","unstructured":"FDA\/CFSAN Dietary Supplement Health and Education Act of 1994. www.cfsan.fda.gov\/udms\/dietsupp.html. Accessed November 17, 2007."},{"key":"bibr105-17455057.4.2.163","unstructured":"FDA takes action against compounded menopause hormone therapy drugs. www.fda.gov\/bbs\/topics\/NEWS\/2008?NEW01772.html Accessed January 11, 2008."}],"container-title":["Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/17455057.4.2.163","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.2217\/17455057.4.2.163","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/17455057.4.2.163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T18:12:33Z","timestamp":1741630353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.2217\/17455057.4.2.163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.2217\/17455057.4.2.163"],"URL":"https:\/\/doi.org\/10.2217\/17455057.4.2.163","relation":{},"ISSN":["1745-5057","1745-5065"],"issn-type":[{"value":"1745-5057","type":"print"},{"value":"1745-5065","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}